ADMA Biologics(ADMA) - 2025 Q3 - Earnings Call Transcript
ADMA Biologics (NasdaqGM:ADMA) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Company ParticipantsAnthony Petrone - Managing Director Equity ResearchBrad Tade - CFO and TreasurerGary Nachman - Managing DirectorAdam Grossman - President and CEOBrian Denyeau - VP of Investor RelationsConference Call ParticipantsRick Miller - AnalystOperatorGood afternoon, and welcome to the ADMA Biologics third quarter 2025 financial results and business update conference call on Wednesday, November 5th, 2025. At this ti ...